Form 4 Filing for GENELUX Corp

Thomas John, a director at GENELUX Corp, acquired 28,409 shares of Common Stock on June 16, 2026, with a transaction price of $0.0. This brings his total post-transaction shares to 501,193. Additionally, John was granted a stock option (right to buy) for 31,566 shares of common stock, also on June 16, 2026, with a $0.0 transaction price. The option has an exercise price of $3.03 and is set to expire on June 15, 2036. The RSUs and stock options granted will vest on the earlier of the one-year anniversary of the grant date or the Issuer's next annual meeting of stockholders.